AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12432338
Drug: 5 mg/day
RxNorm normalized name: Lyllana 0.05 MG/Day Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/day tamoxifen (n=16)
Trial: 12432338
Drug: 10 mg/day
RxNorm normalized name: Adlarity 10 MG/Day Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/day tamoxifen (n=16)
Trial: 12432338
Drug: 20 mg/day
RxNorm normalized name: futibatinib 20 mg/day (4 mg x 5) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/day tamoxifen (n=15)
Trial: 10525131
Drug: LDL-apheresis (LA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDL-apheresis (LA) combined with simvastatin 40 mg per day
Trial: 8624230
Drug: Oscillating/rotating brush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oscillating/rotating brush (Braun Oral‐B Plaque Remover)
Trial: 7400475
Drug: Oral theophylline
RxNorm normalized name: theophylline Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral theophylline solution
Trial: 7400475
Drug: Rectal theophylline
RxNorm normalized name: Theophylline
DrugBank: Theophylline (DB00277)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rectal theophylline solution
Trial: 30088266
Drug: i-gel™ laryngeal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i-gel™ laryngeal mask
Trial: 23506128
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol (50 mcg every 4 hours)
Trial: 31640452
Drug: Office-based vergence/accommodative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Office-based vergence/accommodative therapy (OBVAT)
Trial: 17902524
Drug: Vaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginal misoprostol (50 micrograms every 4-6 hours, max six doses)
Trial: 17902524
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol (50 micrograms every 4-6 hours, max six doses)
Trial: 9235216
Drug: Combined phenibut
RxNorm normalized name: phenibut
DrugBank: Phenibut (DB13455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined phenibut (0.25 g) with obsidan (0.08 g)
Trial: 9235216
Drug: Bemethyl (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bemethyl (0.5 g)
Trial: 9235216
Drug: Obsidian (0.08
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Obsidian (0.08 g)
Trial: 8444102
Drug: Halofantrin (three
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Halofantrin (three doses of 500 mg)
Trial: 8444102
Drug: Halofantrin (one-day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Halofantrin (one-day therapy)
Trial: 3028964
Drug: Non-absorbable antimicrobial
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-absorbable antimicrobial drugs (polymyxin and neomycin)
Trial: 31164006
Drug: Treatment-resistant schizophrenia
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-resistant schizophrenia
Trial: 27580103
Drug: Tilmicosin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tilmicosin (20 mg/kg, SC) once at dry off
Trial: 27580103
Drug: Tilmicosin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tilmicosin (20 mg/kg, SC) twice (once at dry off and again 20 days later)
Trial: 27580103
Drug: Ceftiofur (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftiofur (500 mg/mammary gland) at dry off
Trial: 21279932
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg Atorvastatin daily for 6 months
Trial: 21279932
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg Atorvastatin daily for 6 months
Trial: 21279932
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg Atorvastatin daily for 6 months
Trial: 21279932
Drug: High-dose atorvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose atorvastatin therapy
Trial: 18359821
Drug: Topical glyceryl
RxNorm normalized name: glyceryl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical glyceryl trinitrate (GTN) therapy with physical therapy
Trial: 18359821
Drug: Standard nonoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard nonoperative physical therapy
Trial: 18359821
Drug: Topical glyceryl
RxNorm normalized name: glyceryl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical glyceryl trinitrate (GTN) therapy
Trial: 18359821
Drug: Standard nonoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard nonoperative therapy
Trial: 16238586
Drug: Dpt specific
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dpt specific immunotherapy (IT)
Trial: 12030918
Drug: GHRP-2 +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GHRP-2 + TRH + GnRH infusion
Trial: 12030918
Drug: GHRP-2 +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GHRP-2 + TRH infusion
Trial: 10720964
Drug: High-fiber diet
RxNorm normalized name: fiber
DrugBank: Calcium polycarbophil (DB14684)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fiber diet (> 25 g/day)
Trial: 18476119
Drug: Butoconazole nitrate
RxNorm normalized name: Butoconazole Nitrate
DrugBank: Butoconazole (DB00639)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Butoconazole nitrate 2% cream for 3 days
Trial: 18476119
Drug: Miconazole nitrate
RxNorm normalized name: Miconazole Nitrate
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Miconazole nitrate 2% cream for 7 days
Trial: 1593018
Drug: Human alpha
RxNorm normalized name: Human alphaherpesvirus 1 Ag
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human alpha leukocyte interferon (IFN) 50,000 IU, 1 ml, twice a week for 4-6 weeks
Trial: 1593018
Drug: Human alpha
RxNorm normalized name: Human alphaherpesvirus 1 Ag
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human alpha leukocyte interferon (IFN) 50,000 IU, 1 ml, twice a week for 4-6 weeks + IL-2
Trial: 4041688
Drug: Family management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family management based on behavioural family therapy
Trial: 28538111
Drug: Antisense oligonucleotide
RxNorm normalized name: Antisense oligonucleotide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antisense oligonucleotide targeting ANGPTL3 mRNA (single dose: 20, 40, or 80 mg; multiple doses: 10, 20, 40, or 60 mg per week for 6 weeks)
Trial: 25320185
Drug: Protein intake
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein intake of 0.2 to 2.0 g · kg(‐1) · d(‐1)
Trial: 20729765
Drug: Isoflavones (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoflavones (80 mg daily for 4 months)
Trial: 19482863
Drug: Intramuscular interferon
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular interferon beta-1a (IFNbeta-1a) 30 mug once weekly
Trial: 16549833
Drug: COL-3 (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COL-3 (50 mg/d)
Trial: 16549833
Drug: COL-3 (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COL-3 (100 mg/d)
Trial: 16549833
Drug: COL-3 (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COL-3 (50 mg/d and 100 mg/d)
Trial: 12637625
Drug: Enfuvirtide plus
RxNorm normalized name: Enfuvirtide
DrugBank: Enfuvirtide (DB00109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enfuvirtide plus an optimized background regimen of three to five antiretroviral drugs
Trial: 9232087
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone 200 micrograms/q.i.d.
Trial: 9232087
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide 200 micrograms/q.i.d.
Trial: 9232087
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (not requiring steroids)
Trial: 26023227
Drug: l-Citrulline (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-Citrulline (6 g/day)
Trial: 26023227
Drug: l-Arginine (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-Arginine (6 g/day)
Trial: 23473847
Drug: Three-drug ART
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three-drug ART (NNRTI, lamivudine, abacavir)
Trial: 23473847
Drug: Four-drug ART
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four-drug ART (NNRTI, lamivudine, abacavir, zidovudine)
Trial: 22036246
Drug: Insulin lispro
RxNorm normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin lispro mix 50/50 (TID group)
Trial: 22036246
Drug: Insulin lispro
RxNorm normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin lispro mix 75/25 or biphasic insulin aspart 70/30 (BID group)
Trial: 15670201
Drug: Anastrozole 1
RxNorm normalized name: anastrozole 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole 1 mg daily (n = 12)
Trial: 15670201
Drug: Anastrozole 1
RxNorm normalized name: anastrozole 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole 1 mg twice weekly (n = 11)
Trial: 15670201
Drug: Placebo daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo daily (n = 14)
Trial: 9480230
Drug: Standard insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard insulin treatment without Camit-Diacomp system
Trial: 8173753
Drug: Inhaled PGE2
RxNorm normalized name: PGE2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Inhaled PGE2
Trial: 29618162
Drug: Tinzaparin (175
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tinzaparin (175 IU/kg once daily)
Trial: 26805417
Drug: Formulation containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formulation containing 4‐t‐butylcyclohexanol
Trial: 26805417
Drug: Cream base
RxNorm normalized name: Cream Base
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cream base containing 4‐t‐butylcyclohexanol and licochalcone A
Trial: 23128469
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 supplementation (2,000 IU once daily for 12 weeks)
Trial: 20795425
Drug: 15 mL
RxNorm normalized name: ethanol 0.15 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mL fish oil daily (550 mg eicosapentaenoic acid; 205 mg decosahexaenoic acid)
Trial: 20795425
Drug: 15 mL
RxNorm normalized name: ethanol 0.15 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mL fish oil daily
Trial: 12826985
Drug: bupropion (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupropion (150 mg) once daily
Trial: 12826985
Drug: bupropion (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupropion (300 mg)
Trial: 12826985
Drug: methylphenidate SR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: methylphenidate SR (20 mg daily)
Trial: 11256129
Drug: Total intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total intravenous anaesthesia using Propofol/Sufentanil (TIVA)
Trial: 9006528
Drug: 7‐mg/kg cefdinir,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7‐mg/kg cefdinir, twice daily, for 5 days
Trial: 9006528
Drug: 10‐mg/kg penicillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10‐mg/kg penicillin V potassium, 4 times daily, for 10 days
Trial: 8314358
Drug: cilazapril (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cilazapril (5 mg o.d.)
Trial: 8314358
Drug: atenolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atenolol (100 mg o.d.)
Trial: 23204220
Drug: Oral cholecalciferol
RxNorm normalized name: cholecalciferol Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cholecalciferol 2000 IU/day
Trial: 21543930
Drug: Time from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Time from primary treatment to recurrence
Trial: 17715049
Drug: Propofol target
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol target controlled infusion (TCI)
Trial: 15549974
Drug: Diprivan mixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diprivan mixed with lidocaine 10 mg
Trial: 11911312
Drug: 5-FU intravenous
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-FU intravenous injection at 1000 mg/m2 body surface area/24 hours for 72 hours + oral HCFU 300 mg daily for 52 weeks (Group B)
Trial: 11911312
Drug: 5-FU intravenous
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-FU intravenous injection at 333 mg/m2 body surface area/24 hours for 72 hours + oral HCFU 300 mg daily for 52 weeks (Group A)
Trial: 2493100
Drug: Placebo ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo ointment base
Trial: 28853303
Drug: DASHNa‐CC intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DASHNa‐CC intervention (Dietary Approach to Stop Hypertension With Sodium Reduction for Chinese Canadian)
Trial: 28853303
Drug: DASHNa‐CC intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DASHNa‐CC intervention
Trial: 23562009
Drug: Daclizumab HYP
RxNorm normalized name: Daclizumab
DrugBank: Daclizumab (DB00111)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Daclizumab HYP 150 mg
Trial: 23562009
Drug: Daclizumab HYP
RxNorm normalized name: Daclizumab
DrugBank: Daclizumab (DB00111)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Daclizumab HYP 300 mg
Trial: 21796092
Drug: PEVAR with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEVAR with adjunctive 'pre-close' techniques using ProGlide or Prostar XL devices
Trial: 19921354
Drug: Landiolol infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Landiolol infusion (0.125 mg kg(‐1) min(‐1) for 1 min, then 0.04 mg kg(‐1) min(‐1) until extubation)
Trial: 16963585
Drug: Pharmacologic antidepressant
RxNorm normalized name: COPD pharmacologic substance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacologic antidepressant treatment
Trial: 15673949
Drug: Piroxicam 20
RxNorm normalized name: piroxicam 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piroxicam 20 mg/day for 3 weeks
Trial: 15673949
Drug: Meloxicam 15
RxNorm normalized name: meloxicam 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meloxicam 15 mg/day for 3 weeks
Trial: 2265331
Drug: Intravenous Avafortan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous Avafortan
Trial: 2265331
Drug: Second dose
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Second dose of prostaglandin synthetase inhibitors
Trial: 26341820
Drug: Brief support
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brief support (monthly weigh-ins and meeting)
Trial: 26341820
Drug: Daily self-weighing
RxNorm normalized name: DAILY SELF DISCOVERY SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily self-weighing (with brief monthly feedback)
Trial: 20430112
Drug: Rate-controlling medications
RxNorm normalized name: tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rate-controlling medications
Trial: 15714841
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (medication with methylphenidate plus consultation)
Trial: 10405869
Drug: Twice a
RxNorm normalized name: Pataday Twice A Day Relief
DrugBank: Olopatadine (DB00768)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice a year deworming with single dose mebendazole
Trial: 19700413
Drug: Cryotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cryotherapy and podophyllotoxin 0.15% cream
Trial: 17933157
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg of risperidone
Trial: 15292666
Drug: Hypericum extract
RxNorm normalized name: Hypericum extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypericum extract LI160 (300 mg twice a day for 2 weeks)
Trial: 8262685
Drug: Nicotine transdermal
RxNorm normalized name: NICOTINE TRANSDERMAL KIT
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine transdermal therapeutic system (TTS)
Trial: 8262685
Drug: Placebo transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo transdermal therapeutic system (TTS)
Trial: 3898725
Drug: Citalopram (20-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (20-80 mg, most frequently 40 mg)
Trial: 3898725
Drug: Mianserin (60-120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mianserin (60-120 mg, most frequently 90 mg)
Trial: 29283682
Drug: High-flow nasal
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-flow nasal cannula oxygen therapy plus long-term oxygen therapy
Trial: 29283682
Drug: Long-term oxygen
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term oxygen therapy only
Trial: 23412098
Drug: Gemcitabine +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine + 400 mg upamostat (arm C)
Trial: 23412098
Drug: Gemcitabine +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine + 200 mg upamostat (arm B)
Trial: 16641530
Drug: Epidural continuous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural continuous infusion without an initial dose (continuous group)
Trial: 16641530
Drug: Epidural continuous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural continuous infusion with an initial dose (initial dose group)
Trial: 11050836
Drug: Cefuroxime 750
RxNorm normalized name: cefuroxime 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime 750 mg t.i.d, i.v.
Trial: 11050836
Drug: Cephradine 1
RxNorm normalized name: cephradine 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cephradine 1 g q.i.d., i.v.
Trial: 8617907
Drug: Exercise for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise for 60 minutes twice a week for 6 months
Trial: 22143257
Drug: Daily educational
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily educational text messages for 180 days
Trial: 21695161
Drug: Praziquantel 60
RxNorm normalized name: praziquantel 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Praziquantel 60 mg/kg
Trial: 20549040
Drug: Intravitreal injection
RxNorm normalized name: Eylea 2 MG per 0.05 ML Intravitreal Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal injection of 4 mg triamcinolone acetonide
Trial: 14993078
Drug: Chizukit (herbal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chizukit (herbal preparation containing 50 mg/mL of echinacea, 50 mg/mL of propolis, and 10 mg/mL of vitamin C)
Trial: 9088587
Drug: Ketoconazole (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole (200 mg day‐1 for 14 days)
Trial: 30234415
Drug: Clovinol (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clovinol (250 mg per day)
Trial: 27396951
Drug: Bevacizumab (alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab (alone or in combination with CCNU)
Trial: 25072529
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (CRFD treatment followed by supplementary application)
Trial: 7144047
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups underwent treatment based on diet and increased physical exercise for two years
Trial: 26057484
Drug: Collagen/thrombin/autologous platelet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collagen/thrombin/autologous platelet haemostatic agent
Trial: 21469388
Drug: gelatin sponge
RxNorm normalized name: ABSORBABLE GELATIN SPONGE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gelatin sponge patch bonded repair group
Trial: 19460684
Drug: Inhaled dornase
RxNorm normalized name: dornase alfa Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled dornase alfa administered 30 minutes before airway clearance therapy (ACT)
Trial: 19460684
Drug: Inhaled dornase
RxNorm normalized name: dornase alfa Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled dornase alfa administered before bedtime or upon awakening
Trial: 19460684
Drug: Inhaled dornase
RxNorm normalized name: dornase alfa Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled dornase alfa
Trial: 17011315
Drug: Baclofen (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baclofen (0.5 mg/kg)
Trial: 15279069
Drug: Rosiglitazone (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone (8 mg, po)
Trial: 3113975
Drug: Flunarizine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunarizine (10 mg orally at bedtime)
Trial: 3113975
Drug: Flunarizine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunarizine (10 mg at bedtime)
Trial: 3113975
Drug: Domperidone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone (10 mg) and gonadotropin releasing hormone (100 micrograms)